A second scRNAseq dataset, based on T cell samples isolated from the blood, tumor tissue, and healthy adjacent tissue from treatment-naïve NSCLC patients was used to further evaluate GPR56 mRNA expression in the TIL repertoire. Here, ADGRG1 is linked to neoplasm.